Opera Limited trades at $19.51, off 2.6% on the week, with Q2 results due September 3 — and the most telling signal heading into that print isn't in the short book or the options market. It's the insider register, where every recent trade has been a sale.
The insider selling warrants attention. Parent company Kunlun Tech offloaded roughly 666,000 shares in late June at $16.01, a transaction worth over $10.6 million. Around the same time, both the Co-CEO and CFO each sold 70,000 shares across two days at prices between $18.52 and $18.88. Combined, net insider activity over the past 90 days represents roughly $13.3 million in outflows. The pattern — parent company trimming alongside simultaneous C-suite liquidations — is the kind of coordinated selling that warrants scrutiny, even if it follows a strong year-to-date run.
Short positioning tells a much quieter story. Short interest is running at around 1.4 million shares, up roughly 36% over the past month but still a modest absolute figure; the float percentage data isn't available, though the lending market shows no meaningful stress. Borrow cost is 0.51%, near the low end of its range for the past six weeks. Availability is generous at roughly 292% — meaning nearly three shares remain available to borrow for every one already lent out. That's well above the 52-week trough of 12%, which the market touched during a considerably tighter episode earlier this year. The ORTEX short score sits at 52.5, mid-range and barely moving, confirming this isn't a stock where the short side is building conviction.
Options positioning is similarly calm, leaning mildly bullish. The put/call ratio is at 0.55, slightly below its 20-day average of 0.56, and about 1.4 standard deviations on the call-heavy side. That's the opposite of the defensive hedging you'd normally see ahead of an uncertain earnings print. Options traders, at least, aren't bracing for a downside shock.
The analyst community remains constructive, though the most recent formal action on record — Goldman Sachs cutting its target to $21.50 in January 2026 — is now seven months stale. The consensus mean target across coverage is $26.17, implying roughly 34% upside from current levels. That's a wide gap for a stock trading at a P/E of 12.6 and an EV/EBITDA of 8.9, both of which have barely moved over the past month. The dividend score ranks in the 93rd percentile, an unusual bright spot for a small-cap software name. Forward EPS growth scores rank in the 20th percentile, which is the tension at the heart of the bull case: the stock is cheap, the yield is real, but forward earnings momentum is weak. The one prior earnings reaction on record — April 2026, when the stock rose 2.6% on the day and 9.1% over the following week — provides a single data point of cautious encouragement.
The institutional picture reflects a concentrated ownership structure: Kunlun holds 67.4% of shares, leaving genuine float thin. Several smaller managers — American Century, Arrowstreet, Penn Capital — added shares into June quarter-end, providing some support from the long side even as the parent trims. What to watch on September 3 is whether management's operating commentary addresses the pace of monetisation in emerging markets, where Opera's browser franchise generates most of its ad revenue, and whether Kunlun's continued share reduction program is mentioned or accelerated.
See the live data behind this article on ORTEX.
Open OPRA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
